Enzyme Inhibition Notes

Enzyme Inhibition

Enzyme Inhibition

  • Inhibitors are compounds/ions that decrease an enzyme’s activity; they alter enzyme’s KMand/orand/orV{max} values.

1. Irreversible inhibitors (inactivators) react with the enzyme.
  • Chemical modification of the enzyme results in inactivation.

  • One inhibitor molecule can permanently shut off one enzyme molecule.

  • Usually bind covalently, but sometimes by non-covalent binding with very high affinity.

  • They are often powerful toxins, but also may be used as drugs (e.g., penicillin, amoxicillin)

  • Labeling used to determine catalytic serines for serprotease

  • Covalently modify bacteria that synthesize cell wall

2. Reversible inhibitors bind to and can dissociate from the enzyme.
  • They are often structural analogs of substrates or products.

  • They are often used as drugs to slow down a specific enzyme.

    • Reversible inhibitor can bind to:

      • The free enzyme and prevent the binding of the substrate (competitive).

      • The enzyme-substrate complex and prevent the reaction (uncompetitive).

      • The free enzyme or the enzyme-substrate complex (non-competitive)

    • Noncovalent Interaction.

Classes of Reversible Inhibitors

  • All can utilize Michaelis-Menten Kinetics!

    • Competitive: Inhibitor binds to the enzyme, preventing substrate binding.

    • Uncompetitive: Inhibitor binds to the enzyme-substrate complex.

    • Noncompetitive: Inhibitor can bind to either the free enzyme or the enzyme-substrate complex.

      • Can act like both competitive and uncompetitive inhibitors.

Reversible Inhibitors – Competitive

  • Competitive inhibition: The inhibitor is structurally similar to the substrate and can bind to the active site, preventing the actual substrate from binding.

  • The inhibitor can bind but it can't react like substrate

  • Can be relieved by increase substrate concentration, outcompete the inhibitors for the active site

Competitive Inhibitors

  • Role: reduce

  • Dihydrofolate reductase

  • To synthesize purines/pyrimidines.

Substrate
  • Dihydrofolate

Inhibitor
  • Methotrexate

    • Struct. analog

    • bind 1000x better

Competitive Inhibitors

  • Product inhibition – negative feedback loops

  • Product accumulates and competes for active site

  • How cell controls activities of its enzymes

Transition State Analogs

  • KM=3×105MK_M = 3 × 10^{−5} M

  • KI=3×104MK_I = 3 × 10^{−4} M

  • KI=1.5×1013MK_I = 1.5 × 10^{−13} M

  • KIK_I = Dissociation constant for enzyme-inhibitor binding

  • Effective catalysis often depends on an enzyme’s ability to bind to and stabilize its reaction’s transition state.

  • Example: 1,6-Dihydroinosine inhibits adenosine deaminase

  • Transition State Analogs are Strong Competitive Enzyme Inhibitors

  • Inhibitor bind better to enz

Human Immunodeficiency Virus Protease inhibitors

  • HIV protease substrate

  • Bond to be cleaved

    • Saquinavir: KI=0.40nMK_I= 0.40 nM

    • Ritonavir: KI=0.015nMK_I= 0.015 nM

Competitive Inhibition

  • A competitive inhibitor is typically a structural analog of the substrate which binds at the active site as the substrate does, and thus prevents the substrate from binding.

  • Competitive Inhibitor Binding at Active Site of Enzyme

Competitive Inhibition: Mechanism

  • Competes with substrate for binding

    • Binds active site

    • Does not affect catalysis

  • The dissociation constant of the inhibitor: KI=[E][I][EI]K_I = \frac{[E][I]}{[EI]}

  • A competitive inhibitor reduces the [free enzyme] available for substrate binding.

  • Enz still can bind substrate then produce products

  • KcatK_{cat}

  • Inhibitor binds eat well

Competitive Enzyme Inhibition: Elucidation of ATP- Binding

  • Comparing the KIK_I values of competitive inhibitors with different structures

  • Provide information about the binding properties of an enzyme’s active site and hence its catalytic mechanism.

Competitive Inhibition: Kinetic Parameters

  • No change in VmaxV_{max}; substrate can outcompete inhibitor

  • Apparent increase in K<em>MK<em>M (K</em>Mapp=αKMK</em>{M}^{app} = αK_M)

    • α: a function of the inhibitor’s concentration and its affinity for the enzyme (cannot be less than 1)

    • α=1+[I]KIα = 1 + \frac{[I]}{K_I}

  • KMK_M increase by the factor

    • Which ran reaches its max velocity

    • Max rate of rxn when all enz active sites saturated

    • If two inhibitor then KMK_M with inhibitor

Competitive Inhibition: Kinetic Curves

  • Michaelis-Menten resulting equation that has been modified by a factor α

  • No change in VmaxV_{max}

  • Bound inhibitor does not inactivate the enzyme.

  • Inhibition can be overcome by sufficiently high [S]

  • Does not affect turnover number (kcatk_{cat})

  • Apparent increase in KMbythefactorα(by the factor α (K{M}^{app} = αK_M)

  • Presence of [I], [S] appear to be less

  • Having inhibitors, enz rxn needs higher [S] to reach half its maximum velocity

Competitive Inhibition: Lineweaver Burk

  • Equation for a double-reciprocal plot in the presence of a competitive inhibitor is:

  • lines intersect at the y-axis:

  • Inhibitor has no effect on V{max}butincreasesbut increasesKM

Uncompetitive Inhibition

  • An uncompetitive inhibitor binds only to the enzyme–substrate complex.

  • No bind free Enz

  • Can't be overcome by Is

Uncompetitive Inhibition

  • An uncompetitive inhibitor binds only to the enzyme-substrate complex.

Uncompetitive Inhibition: Mechanism

  • Only binds to ES complex

  • Does not affect substrate binding

  • Inhibits catalytic function

  • The dissociation constant of the inhibitor: KI=[ES][I][ESI]K_I’ = \frac{[ES][I]}{[ESI]}

  • An uncompetitive inhibitor bind at a site distinct from the active site, distorting the active site to make enzyme catalytical inactive

  • No need for inhibitor to be structurally similar to substrate.

  • Lowering KSK_S stronger Inhibition

Uncompetitive Inhibition: Kinetic Parameters

  • Enzyme-inhibitor-substrate complex doesn’t form product.

  • The apparent V<em>maxV<em>{max} (V</em>maxapp=V<em>maxαV</em>{max}^{app} = \frac{V<em>{max}}{α’}) is lower in the presence of inhibitor; K</em>MK</em>M (K<em>Mapp=K</em>MαK<em>{M}^{app} = \frac{K</em>M}{α’}) is also lower.

  • No change in K<em>M/V</em>maxK<em>M/V</em>{max}

  • Inhibition cannot be overcome by sufficiently high [S]

    • Binding substrate => No interference with inhibitor

  • α=1+[I]KIα’ = 1 + \frac{[I]}{K’_I}

  • KMK_M Kind by factor

  • Catalytic function of ESI enz affected

  • VmaxV_{max} by factor of

Uncompetitive Inhibition: Kinetic Curves

  • Adding [S] does not reverse the uncompetitive inhibition affect

  • [S] approaches infinity, Vo can no longer reach VmaxV_{max} for any value of α

  • Reduced k{cat}(Note:(Note:k{cat} = V{max}/[Enzyme]{total}

Uncompetitive Inhibition: Lineweaver Burk

  • lines are parallel:

Noncompetitive Inhibition

  • A noncompetitive inhibitor binds to either the free enzyme or the enzyme–substrate complex and does not prevent the substrate from binding to the enzyme

Mixed Inhibition (Noncompetitive)

  • Noncompetitive inhibition: The inhibitor binds either the enzyme or enzyme-substrate complex.

Noncompetitive Inhibition: Mechanism

  • Binds enzyme with or without substrate

    • Binds to regulatory site (distinct from the active site)

    • Inhibits both substrate binding and catalysis

  • The dissociation constant of the inhibitor: KI = \frac{[E][I]}{[EI]} & KI’ = \frac{[ES][I]}{[ESI]}

  • Ex metal ions Tithe and ES

Noncompetitive Inhibition: Mechanism

  • Decrease in V<em>maxV<em>{max} (V</em>maxapp=VmaxαV</em>{max}^{app} = \frac{V_{max}}{α’}

  • K<em>MK<em>M can increase or decrease (K</em>Mapp=Km(αα)K</em>{M}^{app} = K_m(\frac{α}{α’})) or remain unchanged for pure noncompetitive inhibition (where inhibitor binds equally well to E and ES so α = α’)

  • Inhibition cannot be overcome by sufficiently high [S]

  • Either bind prevent the formation ofKIpropK_{I prop}

  • KMK_M to

Noncompetitive Inhibition: Kinetic Curves

  • Adding [S] does not reverse the uncompetitive inhibition affect

  • [S] approaches infinity, Vo can no longer reach Vmax for any value of α

  • Reduced kcat

  • KM may or may not change

  • If depend on us is

Noncompetitive Inhibition: Lineweaver Burk

  • lines intersect left from the y-axis:

Summary of Enzyme Inhibitor Effects

  • Effects of Inhibitors on Michaelis-Menten Reactions

  • Effects of Reversible Inhibitors on V<em>maxV<em>{max} and Apparent K</em>MK</em>M

Enzyme-Catalyzed Reaction

  • If the red line represents the rate of an enzyme-catalyzed reaction in the presence of a competitive inhibitor, which line represents the activity of the same enzyme in the absence of the inhibitor?

Enzyme Inhibition Summary

  • comp Inh No VmaxV_{max}

  • Is will overcome inhibition

  • Km THEY

  • Kmt for comp inh US kind w o inhibitor